Vivanza Biosciences Board Meeting Scheduled for 3rd Nov'26 to Consider Q2 Results
Vivanza Biosciences Ltd 路 Intimation 路 03 Nov 2026, 5:30 am
Vivanza Biosciences Board Meeting Scheduled for 3rd Nov'26 to Consider Q2 Results Vivanza Biosciences Limited has scheduled a meeting of its Board of Directors on 3rd Nov'26 to consider and approve the unaudited standalone and consolidated financial results, along with the limited review report, for the quarter and half-year ended 30th Sep'26. In compliance with insider trading regulations, the trading window for dealing in company securities by designated persons and key managerial personnel remains closed until 48 hours after the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Vivanza Biosciences Ltd
- Pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform .... 路 07 Nov 2026
- Non-applicability of Reg 23 (9) of SEBI (LODR) Regulation, 2015 for the Quarter on 30th September, 2026. 路 29 Oct 2026
- Non applicability of the statements of Variation and Deviation under regulation 32 of SEBI LODR Regulation, 2015 as Company has not raised any further funds, hence statements of Deviation .... 路 08 Oct 2026
- Voting Result for the 44th Annual General Meeting of the Company 路 12 Sept 2026
- Revised Outcome of the 44th Annual General Meeting of the Vivanza Biosciences Limited 路 12 Sept 2026
- Outcome of the 44th Annual General Meeting of the Members of the Vivanza Biosciences Limited. 路 11 Sept 2026
- Please find enclosed newspaper advertisement w.r.t Notice of 44th AGM of the Company and e-voting information. 路 20 Aug 2026
- Annual Report for the Financial Year 2025-2026 of the Company. 路 19 Aug 2026
